Monoclonal gammopathy of undetermined significance
Author:
Affiliation:
1. The Center for Prevention of Progression of Blood Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
Abstract
Publisher
American Society of Hematology
Subject
Cell Biology,Hematology,Immunology,Biochemistry
Link
http://ashpublications.org/blood/article-pdf/133/23/2484/1553607/bloodbld2019846782c.pdf
Reference141 articles.
1. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study;Landgren;Blood,2009
2. Advances in the diagnosis, classification, risk stratification, and management of monoclonal gammopathy of undetermined significance: implications for recategorizing disease entities in the presence of evolving scientific evidence;Rajkumar;Mayo Clin Proc,2010
3. A long-term study of prognosis in monoclonal gammopathy of undetermined significance;Kyle;N Engl J Med,2002
4. IgM monoclonal gammopathy of undetermined significance (MGUS) and smoldering Waldenström’s macroglobulinemia (SWM);Kyle;Clin Lymphoma Myeloma Leuk,2011
5. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group;International Myeloma Working Group;Br J Haematol,2003
Cited by 57 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Clearing soluble MIC reverses the impaired function of natural killer cells from patients with multiple myeloma;Journal for ImmunoTherapy of Cancer;2024-01
2. Association of lipid levels, adipokines and multiple myeloma: a two-sample multivariate Mendelian randomization study;2023-12-16
3. Identification of novel loci for multiple myeloma when comparing with its precursor condition monoclonal gammopathy of unknown significance;Leukemia;2023-11-02
4. Geographic Prevalence Patterns and Modifiable Risk Factors for Monoclonal Gammopathy of Undetermined Significance;Hemato;2023-11-01
5. Growth and dormancy control of myeloma cells by mesenchymal stem cells;Leukemia Research;2023-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3